<p>H2596 cells were treated with ARQ 197, GDC-0980, NVP-BEZ235 alone and in combination for 48 h. Cell cycle profile was determined using flow cytometry after staining with PI/RNase. <b>Fig.</b><b>A</b> shows the percentage of cells in G1, S, and G2/M phases was quantified and the results expressed as the mean ± SEM of four independent experiments. H2596 <b>(B)</b> and H513 <b>(C)</b> cells, were treated with ARQ 197, GDC-0980, NVP-BEZ235 alone and in combination for 48 h. Cell lysates were prepared and immunoblotted for total PARP, cleaved PARP, cyclin D1 and actin as a loading control. H2596 cells treated with ARQ 197, GDC-0980, NVP-BEZ235 alone and in combination for 48 h, the cells were then stained with Annexin V-FITC/PI and analyzed b...
<p>Wound healing assay was performed in H513 and H2596 cells treated with ARQ 197(0.2 µM), GDC-0980 ...
<p>MCF7 cells were plated in MEM medium at different densities from 2X10<sup>5</sup> to 16X10<sup>5<...
<p><b>A</b>) Cell death in CCRF-CEM and NALM6 cells treated with metformin (MET, 4 mM) and the PIM-1...
<p>RT112 and T24 cells were treated with RAD001 (5 nM), NVP-BEZ235 (100 nM for T24, 500 nM for RT112...
<p>(<b>A</b>) The indicated cells were treated for 24 hrs. with rapamycin or BEZ235 and immunoblotte...
<p>(<b>A</b>) OEC-M1 cells were treated with 0.25 or 0.5 μM of MPT0B098 for 12 hrs. Cells were then ...
<p><b>A</b> Cells were either left untreated, treated for 24 µM PI-103, a well-characterized pan-PI3...
Malignant pleural mesothelioma (MPM) is an aggressive disease with a poor prognosis. Studies have sh...
<div><p>BCR-ABL+ (PH and BV) and BCR-ABL- (HP) cells were treated with 0.5µM or 2µM NVP-BKM120 (PI3K...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
<p>(A) Control and AG–4 treated (5.4 μM, 0–48 h) cells were analyzed by western blot for phosphoryla...
<div><p>Malignant pleural mesothelioma (MPM) is an aggressive disease with a poor prognosis. Studies...
<p>H2596 and H513 cells were plated in 10 cm tissue culture plates overnight and next day treated wi...
<p><b>A)</b> G2/M arrest in HCT116 colon cancer cells. HCT116 cells were treated with the indicated ...
<div><p>BCR-ABL+ (BV, PH, KW, CM, BV und DW), TEL-ABL+ (VG) and BCR-ABL- (HP, KR, RL, CR und SK) LTC...
<p>Wound healing assay was performed in H513 and H2596 cells treated with ARQ 197(0.2 µM), GDC-0980 ...
<p>MCF7 cells were plated in MEM medium at different densities from 2X10<sup>5</sup> to 16X10<sup>5<...
<p><b>A</b>) Cell death in CCRF-CEM and NALM6 cells treated with metformin (MET, 4 mM) and the PIM-1...
<p>RT112 and T24 cells were treated with RAD001 (5 nM), NVP-BEZ235 (100 nM for T24, 500 nM for RT112...
<p>(<b>A</b>) The indicated cells were treated for 24 hrs. with rapamycin or BEZ235 and immunoblotte...
<p>(<b>A</b>) OEC-M1 cells were treated with 0.25 or 0.5 μM of MPT0B098 for 12 hrs. Cells were then ...
<p><b>A</b> Cells were either left untreated, treated for 24 µM PI-103, a well-characterized pan-PI3...
Malignant pleural mesothelioma (MPM) is an aggressive disease with a poor prognosis. Studies have sh...
<div><p>BCR-ABL+ (PH and BV) and BCR-ABL- (HP) cells were treated with 0.5µM or 2µM NVP-BKM120 (PI3K...
<p>(<b>A</b>) The indicated cell lines were assessed for viability on the indicated days using CellT...
<p>(A) Control and AG–4 treated (5.4 μM, 0–48 h) cells were analyzed by western blot for phosphoryla...
<div><p>Malignant pleural mesothelioma (MPM) is an aggressive disease with a poor prognosis. Studies...
<p>H2596 and H513 cells were plated in 10 cm tissue culture plates overnight and next day treated wi...
<p><b>A)</b> G2/M arrest in HCT116 colon cancer cells. HCT116 cells were treated with the indicated ...
<div><p>BCR-ABL+ (BV, PH, KW, CM, BV und DW), TEL-ABL+ (VG) and BCR-ABL- (HP, KR, RL, CR und SK) LTC...
<p>Wound healing assay was performed in H513 and H2596 cells treated with ARQ 197(0.2 µM), GDC-0980 ...
<p>MCF7 cells were plated in MEM medium at different densities from 2X10<sup>5</sup> to 16X10<sup>5<...
<p><b>A</b>) Cell death in CCRF-CEM and NALM6 cells treated with metformin (MET, 4 mM) and the PIM-1...